PHARMACEUTICAL PREPARATIONS USED CANCER

Brand Owner (click to sort) Address Description
CANZELIC Vion Pharmaceuticals, Inc. Four Science Park New Haven CT 06511 Pharmaceutical preparations used in cancer therapeutics;
INAUGRA Vion Pharmaceuticals, Inc. Four Science Park New Haven CT 06511 Pharmaceutical preparations used in cancer therapeutics;
LEUCOTROPIN CANGENE CORPORATION 155 Innovation Drive Winnipeg, Manitoba R3T5Y3 Canada PHARMACEUTICAL PREPARATIONS USED IN CANCER THERAPY;
LEUCOTROPIN CANGENE CORPORATION 155 Innovation Drive Winnipeg, Manitoba R3T5Y3 Canada Pharmaceutical Preparations Used in Cancer Therapy;
ONBAZIS Vion Pharmaceuticals, Inc. Four Science Park New Haven CT 06511 Pharmaceutical preparations used in cancer therapeutics;
ONRIGIN Vion Pharmaceuticals, Inc. Four Science Park New Haven CT 06511 Pharmaceutical preparations used in cancer therapeutics;
RYFIONQ Isofol Medical AB (publ) Biotech Center, Sweden Pharmaceutical preparations used for cancer treatment of human patients provided by medical professionals at health care facilities;
TYSTRICTO Isofol Medical AB (publ) Biotech Center, Sweden Pharmaceutical preparations used for cancer treatment of human patients provided by medical professionals at health care facilities;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.